Skip to main content
Denis Miller, MD, Pediatric Hematology & Oncology, Park City, UT

DenisRonaldMillerMD

Pediatric Hematology & Oncology Park City, UT

Pediatric Hematologic Oncology

Adjunct Clinical Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah School of Medicine and Primary Children's Hospital

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Miller's full profile

Already have an account?

  • Office

    8136 North Ranch Club Trail
    Park City, UT 84098

Summary

  • I am a board certified pediatric hematologist/oncologist with over 50 years of clinical practice, laboratory and clinical research, education, and training. A graduate of Cornell University and Cornell University Medical College, I did my residency and fellowship at Boston Children's Hospital and Harvard Medical School. The latter was under the mentorship of Drs. Louis Diamond and D I was Chief of Pediatrics at the 36th Tactical Hospital in Germany. I served on the faculties of the University of Rochester-Strong Memorial Hospital, Cornell Medical Center-New York Hospital, Chairman of the Pediatrics at Memorial Sloan Kettering Cancer Center (MSKCC) and directed its combined Fellowship Training Program. My initial laboratory research focus was in congenital hemolytic anemias (enzyme deficiencies, hemoglobinopathies and membrane defects) but reflecting the realities of my clinical practice, I joined Childrens Cancer Group and became focused on childhood ALL and other hematologic malignancies. I was vice-chairperson of CCG and director of the ALL BM Reference Laboratory. Significant contributions to ALL included definition of clinical and laboratory prognostic groups, the importance of early response to induction therapy, neuropsychologic adverse effects of therapy, sanctuaries of disease, and lymphoblast morphology. I was on the faculty of Northwestern Medical Center, served as Scientific Director of the Cancer Treatment Research Foundation, and then joined the biotechnology/CRO/pharmaceutical industry, and was VP and Global Therapeutic Area Head of Hem/Onc at PAREXEL. I am now Adjunct Professor Clinical Pediatrics at the University of Utah and Primary Childrens Hospital, engaging in teaching and mentoring. I have authored over 300 scientific articles, books, chapters, and abstracts, most noteworthy of which is senior editor and major contributor to editions 4-7 of Smith's Blood Diseases of Infancy and Childhood. I was the 2nd President of ASPHO.

Education & Training

  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1959

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1983 - 2025
  • IL State Medical License
    IL State Medical License 1985 - 1999
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Past President, American Society of Pediatric Hematology-Oncology 1983-1984
  • Fulbright Scholar, University of London, St. Mary's Hospital and Medical School 1961-1962

Publications & Presentations

PubMed

Professional Memberships

Other Languages

  • German